Clinical trial
Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With…
NCT00222131 · University of Kansas Medical Center, Other · Completed
Key facts
| NCT number | NCT00222131 |
|---|---|
| Title | Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients |
| Official title | Inhibition of Gastric Acid Is the Key To Satisfactory Relief of Symptoms and Restoration of the Quality of Life in Patients With Epigastric Pain Related to Non-Ulcer Dyspepsia During Therapy With Esomeprazole |
| Lead sponsor | University of Kansas Medical Center, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Indigestion |
| Intervention type | Drug, Other |
| Interventions | Esomeprazole, Placebo |
| Enrollment | 73 |
| Start date | Oct 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 27, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: